Compare TPR & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPR | MEDP |
|---|---|---|
| Founded | 1941 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0B | 18.3B |
| IPO Year | 2000 | 2016 |
| Metric | TPR | MEDP |
|---|---|---|
| Price | $120.83 | $610.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 14 |
| Target Price | $163.55 | ★ $651.31 |
| AVG Volume (30 Days) | ★ 2.3M | 216.6K |
| Earning Date | 11-05-2026 | 10-21-2026 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | ★ 786.59 | 20.98 |
| EPS | 1.76 | ★ 13.37 |
| Revenue | ★ $5,880,000,000.00 | N/A |
| Revenue This Year | $7.48 | $12.62 |
| Revenue Next Year | $5.17 | $6.03 |
| P/E Ratio | $70.27 | ★ $47.36 |
| Revenue Growth | ★ 31.01 | N/A |
| 52 Week Low | $104.50 | $373.00 |
| 52 Week High | $164.80 | $693.97 |
| Indicator | TPR | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 43.33 | 37.87 |
| Support Level | $110.81 | $575.64 |
| Resistance Level | $120.88 | $636.66 |
| Average True Range (ATR) | 4.64 | 19.74 |
| MACD | -1.01 | -6.25 |
| Stochastic Oscillator | 5.51 | 5.32 |
Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounted for 86% of its revenue and all its operating profit in fiscal 2026. Coach was founded as a leathergoods company in 1941, and handbags represented 58% of its fiscal 2026 revenue. Coach products are sold through nearly 1,000 company-owned stores, company-operated digital channels, and wholesale partners in North America, Asia, and Europe. Tapestry also owns Kate Spade (13% of fiscal 2026 revenue), which operates more than 300 worldwide stores and generated 55% of its revenue from handbags in fiscal 2025. Founded in 1993, Kate Spade is known for its colorful patterns and graphics.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.